US Stock MarketDetailed Quotes
RHE Regional Health Properties
- 1.702
- +0.092+5.70%
Close Nov 27 16:00 ET
3.20MMarket Cap-1098P/E (TTM)
1.710High1.620Low6.30KVolume1.660Open1.610Pre Close10.40KTurnover0.38%Turnover Ratio0.08P/E (Static)1.88MShares3.07552wk High-0.15P/B2.83MFloat Cap1.13052wk Low--Dividend TTM1.66MShs Float27.720Historical High--Div YieldTTM5.59%Amplitude0.720Historical Low1.651Avg Price1Lot Size
Regional Health Properties Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -122.18%-112K | 41.06%505K | -77.01%597K | 203.23%3.71M | 117.68%252K | -19.46%505K | 129.37%358K | 264.47%2.6M | -173.48%-3.6M | -282.23%-1.43M |
| Net income from continuing operations | -0.82%-982K | -3.22%-706K | 51.71%-962K | 43.38%-3.89M | 89.39%-238K | -162.53%-974K | 48.38%-684K | 31.94%-1.99M | -480.96%-6.87M | -239.49%-2.24M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,380.14%1.87M | ---- |
| Depreciation and amortization | -9.89%474K | -26.78%514K | 0.20%511K | -6.20%2.26M | -11.62%517K | -12.33%526K | 15.84%702K | -16.80%510K | -7.22%2.4M | -8.31%585K |
| Other non cash items | -20.00%-60K | -52.59%-383K | 234.15%137K | -78.92%257K | -78.78%517K | 96.27%-50K | -152.07%-251K | 111.45%41K | 147.19%1.22M | 553.63%2.44M |
| Change In working capital | -132.66%-225K | 147.57%1.02M | -78.69%840K | 148.59%3.58M | 72.46%-1.46M | 315.06%689K | 128.37%412K | 605.91%3.94M | -232.77%-7.37M | -601.89%-5.31M |
| -Change in receivables | -137.71%-204K | -70.97%45K | -105.00%-168K | 153.09%3.55M | 78.18%-508K | 159.91%541K | 108.86%155K | 297.94%3.36M | -945.19%-6.68M | -7,375.00%-2.33M |
| -Change in prepaid assets | -216.57%-415K | 27.89%321K | -61.72%209K | 484.77%1.15M | 99.70%-1K | 103.43%356K | -4.92%251K | 480.85%546K | -78.86%197K | -213.51%-336K |
| -Change in payables and accrued expense | 269.18%472K | 267.14%590K | 841.12%793K | -351.91%-1.78M | 56.90%-1.04M | -131.89%-279K | -287.77%-353K | -111.26%-107K | -111.64%-393K | -564.48%-2.41M |
| -Change in other current liabilities | -209.86%-78K | -82.17%64K | -95.86%6K | 232.80%660K | 136.17%85K | 273.68%71K | 333.12%359K | 214.17%145K | -209.96%-497K | -211.37%-235K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -122.18%-112K | 41.06%505K | -77.01%597K | 203.23%3.71M | 117.68%252K | -19.46%505K | 129.37%358K | 264.47%2.6M | -173.48%-3.6M | -282.23%-1.43M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 43.55%-35K | 60.09%-340K | -2,650.00%-55K | -240.93%-958K | 57.14%-42K | -100.00%-62K | -1,083.33%-852K | 97.50%-2K | -128.46%-281K | -2,350.00%-98K |
| Net PPE purchase and sale | 43.55%-35K | 60.09%-340K | -2,650.00%-55K | -240.93%-958K | 57.14%-42K | -100.00%-62K | -1,083.33%-852K | 97.50%-2K | -128.46%-281K | -2,350.00%-98K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 43.55%-35K | 60.09%-340K | -2,650.00%-55K | -240.93%-958K | 57.14%-42K | -100.00%-62K | -1,083.33%-852K | 97.50%-2K | -128.46%-281K | -2,350.00%-98K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 111.14%75K | -23.04%-566K | -9.64%-751K | -20.22%-2.48M | -1,988.57%-661K | 6.92%-673K | 34.38%-460K | -1.78%-685K | 14.62%-2.06M | 106.29%35K |
| Net issuance payments of debt | 111.14%75K | -23.93%-549K | -9.64%-751K | -43.14%-2.46M | -299.70%-661K | 6.92%-673K | 36.80%-443K | -9.25%-685K | 27.94%-1.72M | 159.53%331K |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -557.14%-46K | --0 |
| Net other financing activities | --0 | ---- | ---- | 94.26%-17K | --0 | --0 | ---- | ---- | -1,309.52%-296K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 111.14%75K | -23.04%-566K | -9.64%-751K | -20.22%-2.48M | -1,988.57%-661K | 6.92%-673K | 34.38%-460K | -1.78%-685K | 14.62%-2.06M | 106.29%35K |
| Net cash flow | ||||||||||
| Beginning cash position | -26.54%3.57M | -31.69%3.98M | 7.04%4.18M | -60.31%3.91M | -14.12%4.64M | -11.93%4.87M | -22.58%5.82M | -60.31%3.91M | 31.45%9.85M | -43.93%5.4M |
| Current changes in cash | 68.70%-72K | 57.97%-401K | -110.94%-209K | 104.63%275K | 69.69%-451K | -81.10%-230K | 52.11%-954K | 181.90%1.91M | -352.08%-5.94M | -770.27%-1.49M |
| End cash Position | -24.44%3.5M | -26.54%3.57M | -31.69%3.98M | 7.04%4.18M | 7.04%4.18M | -14.12%4.64M | -11.93%4.87M | -22.58%5.82M | -60.31%3.91M | -60.31%3.91M |
| Free cash flow | -133.18%-147K | 133.40%165K | -79.11%542K | 171.03%2.75M | 113.79%210K | -25.67%443K | 61.74%-494K | 256.42%2.6M | -181.26%-3.88M | -295.76%-1.52M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data